Trade ANRO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Alto Neuroscience Inc. (ANRO) is trading at US$30.15, down 4.85% today as of Sep 15, 12:07 EDT. The company has a market capitalisation of US$1.35B. Over the past 52 weeks, ANRO has traded between US$3.59 and US$37.48. On Syfe you can trade ANRO with $0 commission and add it to your watchlist.
| Previous close | US$31.68 |
|---|---|
| Market cap | US$1.35B |
| 52-week range | US$3.59 – US$37.48 |
| Volume | 453.31K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Alto Neuroscience Inc.
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
Year: 2024
BofA Adjusts Price Target on Alto Neuroscience to $37 From $33
Aug 14, 11:35 AM · MT Newswires
Wedbush Adjusts Price Target on Alto Neuroscience to $26 From $24, Keeps Neutral Rating
Aug 13, 10:49 AM · MT Newswires
Alto Neuroscience Prices $100 Million Stock Offering
Jul 13, 12:22 PM · MT Newswires
BofA Securities Adjusts Price Target on Alto Neuroscience to $33 From $35
May 22, 12:12 PM · MT Newswires
Alto Neuroscience Inc. (ANRO) stock is trading at US$30.15, -4.85% from the previous close of US$31.68.
The market cap for Alto Neuroscience Inc. (ANRO) stock is approximately US$1.35B.
The 52-week high for Alto Neuroscience Inc. (ANRO) stock is US$37.48.
The 52-week low for Alto Neuroscience Inc. (ANRO) stock is US$3.59.
Alto Neuroscience Inc. (ANRO) does not currently pay a dividend.
Stay on top of ANRO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
